Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adachi, M., L. Schneck, J. Cara, and B. W. Volk. 1973. Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan’s disease)A review. Hum Pathol 4:331–347.
Adachi, M., and B. W. Volk. 1968. Protracted form of spongy degeneration of the central nervous system (van Bogaert and Bertrand type). Neurology 18:1084–1092.
Adachi, M., B. J. Wallace, L. Schneck, and B. W. Volk. 1966. Fine structure of spongy degeneration of the central nervous system (van Bogaert and Bertrand type). J Neuropathol Exp Neurol 25:598–616.
Adachi, M., B. J. Wallace, and B. W. Volk. 1967. Ultramicroscopic and histochemical studies of spongy degeneration (van Bogaert and Bertrand type). J Neuropathol Exp Neurol 26:164–165.
Aubourg, P., C. Adamsbaum, M. -C. Lavallard-Rousseau, F. Rocchiccioli, N. Cartier, I. Jambaque, C. Jakobezak, A. Lemaitre, F. Boureau, C. Wolf, and P. -F. Bougneres. 1993. A two-year trial of oleic and erucic acids (“ Lorenzo’s Oil ”) as treatment for adrenomyeloneuropathy. N Engl J Med 329:745–352.
Aubourg, P., S. Blanche, I. Jambaque, F. Rocchiccioli, G. Kalifa, C. Naud-Saudreau, M. O. Rolland, M. Debre, J. L. Chaussain, C. Griscelliet al., 1990. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860–1866.
Aubourg, P., and J. L. Chaussain. 1991. Adrenoleukodystrophy presenting as Addison’s disease in children and adults. Trends Endocrinol Metab 2:49–52.
Banker, B. Q., J. T. Roberson, and M. Victor. 1964. Spongy degeneration of the CNS in infancy. Neurology 14:981–1001.
Baslow, M. 2003. Brain N-Acetylaspartate as a molecular water pump and its role in the etiology of canavan disease: A mechanistic explanation. J Mol Neurosci 21:185–190.
Baslow, M. 2000. Canavan’s spongiform leukodystrophy: A clinical anatomy of a genetic metabolic CNS disease — An analytical review. J. Mol. Neurosci 15:61–69.
Benhamida, S., F. Pflumio, A. Dubart-Kupperschmitt, J. C. Zhao-Emonet, M. Cavazzana-Calvo, F. Rocchiccioli, S. Fichelson, P. Aubourg, P. Charneau, and N. Cartier. 2003. Transduced CD34 + cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol Ther 7:317–324.
Bezaire, V., W. Hofmann, J. K. G. Kramer, L. P. Kozak, and M. -E. Harper. 2001. Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3(-/-) and wild-type mice. Am J Physiol Endocrinol Metab 281:E975–982.
Bezman, L., A. B. Moser, G. V. Raymond, P. Rinaldo, P. A. Watkins, K. D. Smith, N. E. Kass, and H. W. Moser. 2001. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening. Ann Neurol 49:512–517.
Boelens, J. 2006. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 29:413–420.
Breheny, N., E. Geelhoed, J. Goldblatt, and P. O’Leary. 2005. Cost effectiveness of predictive genetic tests for familial breast and ovarian cancer. Genom Soc Pol 1:67–79.
Brismar, J., G. Brismar, G. Gascon, and P. Ozand. 1990. Canavan disease: CT and MR imaging of the brain. AJNR Am J Neuroradiol 11:805–810.
Brockmann, K., P. Dechent, B. Wilken, O. Rusch, J. Frahm, and F. Hanefeld. 2003. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology 60:819–825.
Budka, H., E. Sluga, and W. D. Heiss. 1976. Spastic paraplegia associated with Addison’s disease: Adult variant of adreno-leukodystrophy. J Neurol. 213:237–250.
Canavan, M. 1931. Schilder’s encephalitis periaxialis diffusa. Report of a case in a child agedsixteen and one-half months. Arch Neurol Psychiatry 25:299–308.
Cartier, N., J. Lopez, P. Moullier, F. Rocchiccioli, M. O. Rolland, P. Jorge, J. Mosser, J. L. Mandel, P. F. Bougneres, O. Danoset al., and 1995. Retroviral-mediated gene transfer corrects verylong-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci 92:1674–1678.
Chen, Y. Q., M. A. Rafi, G. de Gala, and D. A. Wenger. 1993. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Mol Genet 2:1841–1845.
Chen, Y. Q., and D. A. Wenger. 1993. Galactocerebrosidase from human urine: Purification and partial characterization. Biochimica et Biophysica Acta (BBA) — Lipids and Lipid Metabolism 1170:53–61.
Crome, L., F. Hanefeld, D. Patrick, and J. Wilson. 1973. Late onset globoid cell leukodystrophy. Brain 96:841–848.
Davidson, B. L., C. S. Stein, J. A. Heth, I. Martins, R. M. Kotin, T. A. Derksen, J. Zabner, A. Ghodsi, and J. A. Chiorini. 2000. From the cover: Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. PNAS 97:3428–3432.
De Gasperi, R., M. A. Gama Sosa, E. L. Sartorato, S. Battistini, H. MacFarlane, J. F. Gusella, W. Krivit, and E. H. Kolodny. 1996. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. Am J Hum Genet 59:1233–1242.
Doerflinger, N., J. M. Miclea, J. Lopez, C. Chomienne, P. Bougneres, P. Aubourg, and N. Cartier. 1998. Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34 + cells. Hum Gene Ther 9:1025–1036.
Eichler, F. S., R. Itoh, P. B. Barker, S. Mori, E. S. Garrett, P. C. M. van Zijl, H. W. Moser, G. V. Raymond, and E. R. Melhem. 2002. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: Initial experience. Radiology 225:245–2452.
Elpeleg, O. N., A. Shaag, Y. Anikster, and C. Jakobs. 1994. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis. J Inherit Metab Dis 17:664–666.
Escolar, M. L., M. D. Poe, J. M. Provenzale, K. C. Richards, J. Allison, S. Wood, D. A. Wenger, D. Pietryga, D. Wall, M. Champagne, R. Morse, W. Krivit, and J. Kurtzberg. 2005. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N Engl J Med 352:2069–2081.
Esiri, M. M., N. M. Hyman, W. L. Horton, and R. H. Lindenbaum. 1984. Adrenoleukodystrophy: Clinical, pathological and biochemical findings in two brothers with the onset of cerebral disease in adult life. Neuropatol Appl Neurobiol 10:429–445.
Eto, Y., J. S. Shen, X. L. Meng, and T. Ohashi. 2004. Treatment of lysosomal storage disorders: Cell therapy and gene therapy. J Inherit Metab Dis 27:411–415.
Farrell, D. F., S. R. Hamilton, T. A. Knauss, E. Sanocki, and S. S. Deeb. 1993. X-linked adrenoleukodystrophy: Adult cerebral variant. Neurology 43:1518–1522.
Fourcade, S., S. Savary, C. Gondcaille, J. Berger, A. Netik, F. Cadepond, M. El Etr, B. Molzer, and M. Bugaut. 2003. Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2). Mol Pharmacol 63:1296–1303.
Fu, L., K. Inui, T. Nishigaki, N. Tatsumi, H. Tsukamoto, C. Kokubu, T. Muramatsu, and S. Okada. 1999. Molecular heterogeneity of Krabbe disease. J Inherit Metab Dis 22:155–162.
Furuya, H., Y. Kukita, S. Nagano, Y. Sakai, Y. Yamashita, H. Fukuyama, Y. Inatomi, Y. Saito, R. Koike, S. Tsuji, Y. Fukumaki, K. Hayashi, and T. Kobayashi. 1997. Adult onset globoid cell leukodystrophy (Krabbe disease): Analysis of galactosylceramidase cDNA from four Japanese patients. Hum Genet 100:450–456.
Hagberg, B., H. Kollberg, P. Sourander, and H. O. Akesson. 1970. Infantile globoid cell leucodystrophy (Krabbe’s disease): A clinical and genetic study of 32 Swedish cases 1953–1967. Neuropaediatrie 1:74–88.
Haq, E., S. Giri, I. Singh, and A. K. Singh. 2003. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem. 86:1428–1440.
Hogan, G. R., L. Gutmann, and S. M. Chou.1969. The peripheral neuropathy of Krabbe’s (globoid) leukodystrophy. Neurology 19:1094–1100
Igisu, H., and K. Suzuki. 1984. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 224:753–755.
Janson, C. G., M. Assadi, J. Francis, L. Bilaniuk, D. Shera, and P. Leone. 2005. Lithium citrate for Canavan disease. Pediatr Neurol 33:235–243.
Janson, C. G., S. W. McPhee, P. Leone, A. Freese, and M. J. During. 2001. Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends Neurosci 24:706–712.
Kaul, R., K. Balamurugan, G. P. Gao, and R. Matalon. 1994. Canavan disease: Genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Genomics 15:364–370.
Kaul, R., G. P. Gao, M. Aloya, K. Balamurugan, A. Petrosky, K. Michals, and R. Matalon. 1994. Canavan disease: Mutations among Jewish and non-jewish patients. Am J Hum Genet 55:34–41.
Kaul, R., G. P. Gao, R. Matalon, M. Aloya, Q. Su, M. Jin, A. B. Johnson, R. B. Schutgens, and J. T. Clarke. 1996. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am J Hum Genet 59:95–102.
Kaul, R., G. Ping Gao, K. Balamurugan, and R. Matalon. 1993. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet 5:118–123.
Kelley, R. 1993. Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid. J Inherit Metab Dis. 16:918–919.
Kemp, S., A. Pujol, H. R. Waterham, B. M. van Geel, C. D. Boehm, G. Raymond, V., G. R. Cutting, R. J. Wanders, and H. W. Moser. 2001. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations. Hum Mutat 18:499–515.
Kennedy, C. R., J. T. Allen, A. H. Fensom, S. J. Steinberg, and R. Wilson. 1994. X-linked adrenoleukodystrophy with non-diagnostic plasma very long chain fatty acids. J Neurol Neurosurg Psychiatry 57:759–761.
Kingsley, P. B., T. C. Shah, and R. Woldenberg. 2006. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 19:435–462.
Kok, F., S. Neumann, C. O. Sarde, S. Zheng, K. H. Wu, H. M. Wei, J. Bergin, P. A. Watkins, S. Gould, G. Sacket al., and 1995. Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum Mutat 6:104–115.
Kolodny, E. H., S. Raghavan, and W. Krivit. 1991. Late-onset Krabbe disease (globoid cell leukodystrophy): Clinical and biochemical features of 15 cases. Dev Neurosci 13:232–239.
Korenke, G. C., H. J. Christen, B. Kruse, D. H. Hunneman, and F. Hanefeld. 1997. Progression of X-linked adrenoleukodystrophy under interferon- Î 2 therapy. J Inherit Metab Dis V20:59–66.
Krabbe, K. 1916. A new familial, infamtile form of diffuse brain sclerosis. Brain 39:74–114.
Krasemann, E. W., V. Meier, G. C. Korenke, D. H. Hunneman, and F. Hanefeld. 1996. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy. Hum Genet 97:194–197.
Krivit, W., E. G. Shapiro, C. Peters, J. E. Wagner, G. Cornu, J. Kurtzberg, D. A. Wenger, E. H. Kolodny, M. T. Vanier, D. J. Loes, K. Dusenbery, and L. A. Lockman. 1998. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 338:1119–1127.
Kronn, D., C. Oddoux, J. Phillips, and H. Ostrer. 1995. Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population. Am J Hum Genet 57:1250–1252.
Kumar, S., N. S. Mattan, and J. de Vellis. 2006. Canavan disease: A white matter disorder. Ment Retard Dev Disabil Res Rev 12:157–165.
Leone, P., C. G. Janson, L. Bilaniuk, Z. Wang, F. Sorgi, L. Huang, R. Matalon, R. Kaul, Z. Zeng, A. Freese, S. W. McPhee, E. Mee, and M. J. During. 2000. Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol 48:27–38.
Libber, S. M., C. J. Migeon, F. R. Brown, and H. W. Moser. 1986. Adrenal and testicular function in 14 patients with adrenoleukodystrophy or adrenomyeloneuropathy. Horm Res 24:1–8.
Ligtenberg, M. J., S. Kemp, C. O. Sarde, B. M. van Geel, W. J. Kleijer, P. G. Barth, J. L. Mandel, B. A. van Oost, and P. A. Bolhuis. 1995. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet 56:44–50.
Loes, D. J., A. E. Stillman, S. Hite, E. Shapiro, L. Lockman, R. E. Latchaw, H. Moser, and W. Krivit. 1994. Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations. AJNR Am J Neuroradiol 15:1767–1771.
Luzi, P., M. A. Rafi, and D. A. Wenger. 1995. Characterization of the large deletion in the GALC gene found in patients with Krabbe disease. Hum Mol Genet 4:2335–2338.
Lyon, G., R. D. Adams, and E. H. Kolodny. 1996. Neurology of Hereditary Metabolic Diseases of Children, 2nd ed. McGraw-Hill, New York.
Lyon, G., B. Hagberg, P. Evrard, C. Allaire, L. Pavone, and V. M. 1991. Symptomatology of late onset Krabbe s leukodystrophy: The European experience. Dev Neurosci 13:240–244.
Maestri, N. E., and T. H. Beaty. 1992. Predictions of a 2-locus model for disease heterogeneity: Application to adrenoleukodystrophy. Am J Hum Genet 44:576–582.
Matalon, R., and K. Michals-Matalon. 1999. Biochemistry and molecular biology of Canavan disease. Neurochem Res 24:507–513.
Matalon, R., K. Michals, and R. Kaul. 1995. Canavan disease: From spongy degeneration to molecular analysis. J Pediatr 127:511–517.
Matalon, R., K. Michals, D. Sebesta, M. Deanching, P. Gashkoff, and J. Casanova. 1988. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 29:463–471.
Matalon, R., P. Rady, K. Platt, H. Skinner, M. Quast, G. Campbell, K. Matalon, J. Ceci, S. Tyring, M. Nehls, S. Surendran, J. Wei, E. Ezell, and S. Szucs. 2000. Knock-out mouse for Canavan disease: A model for gene transfer to the central nervous system. J Gene Med 2:165–175.
Mathew, R., P. Arun, C. N. Madhavarao, J. R. Moffett, and M. A. A. Namboodiri. 2005. Progress toward acetate supplementation therapy for Canavan disease: Glyceryl triacetate administration increases acetate, but not N-Acetylaspartate, levels in brain. J Pharmacol Exp Ther 315:297–303.
Maurice, R. E., and E. Michaela. 2001. The neurobiology and evolution of cannabinoid signalling. Phil Trans R Soc B Biol Sci 356:381–408.
McPhee, S. W., J. Francis, C. G. Janson, T. Serikawa, K. Hyland, E. O. Ong, S. S. Raghavan, A. Freese, and P. Leone. 2005. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease. Brain Res Mol Brain Res 135:112–121.
Migeon, B. R., H. W. Moser, A. B. Moser, J. Axelman, D. Sillence, and R. A. Norum. 1981. Adrenoleukodystrophy: Evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci 78:5066–5070.
Morell, P. R. Quarles, and W. Norton. 1994. Basic Neurochemistry, Raven, NY.
Moser, H. W. 1997. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508.
Moser, H. W., A. B. Moser, N. Kawamura, J. Murphy, K. Suzuki, H. Schaumburg, and Y. Kishimoto. 1980. Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 7:542–549.
Moser, H. W., A. B. Moser, K. D. Smith, A. Bergin, J. Borel, J. Shankroff, O. C. Stine, C. Merette, J. Ott, W. Krivitet al., and 1992. Adrenoleukodystrophy: Phenotypic variability and implications for therapy. J Inherit Metab Dis 15:645–664.
Moser, H. W., G. V. Raymond, and P. Dubey. 2005. Adrenoleukodystrophy: New approaches to a neurodegenerative disease. JAMA 294:3131–3134.
Moser, H. W., K. D. Smith, P. A. Watkins, J. Powers, and A. B. Moser. 2001. X-linked adrenoleukodystrophy, p. 3257–3301. In AL. Beaudet (ed.), The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York.
Moser, H. W., P. J. Tutschka, F. R. Brown, A. E. Moser, A. M. Yeager, I. Singh, S. A. Mark, A. A. Kumar, J. M. McDonnell, C. L. Whiteet al., and 1984. Bone marrow transplant in adrenoleukodystrophy. Neurology 34:1410–1417.
Mosser, J., A. -M. Douar, C. -O. Sarde, P. Kioschis, R. Feil, H. Moser, A. -M. Poustka, J. -L. Mandel, and P. Aubourg. 1993. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730.
Mosser, J., Y. Lutz, M. E. Stoeckel, C. O. Sarde, C. Kretz, A. M. Douar, J. Lopez, P. Aubourg, and J. L. Mandel. 1994. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 3:265–271.
Naidu, S., M. J. Bresnan, D. Griffin, S. O Toole, and H. W. Moser. 1988. Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression. Arch Neurol 45:846–848.
Ory-Lavollee, L., R. D. Blakely, and J. T. Coyle. 1987. Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues. J Neurochem 48:895–899.
Pearce, J. M. 2004. Canavan’s disease. J Neurol Neurosurg Psychiatry 75:1410.
Powers, J. 1985. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex). Clin Neuropathol 4:181–199.
Powers, J. M., H. H. Schaumburg, A. B. Johnson, and C. S. Raine. 1980. A correlative study of the adrenal cortex in adreno-leukodystrophy — evidence for a fatal intoxication with very long chain saturated fatty acids. Invest. Cell Pathol. 3:353–376.
Rafi, M. A., P. Luzi, Y. Q. Chen, and D. A. Wenger. 1995. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Hum Mol Genet 4:1285–1289.
Rizzo, W. B., P. A. Watkins, M. W. Phillips, D. Cranin, B. Campbell, and J. Avigan. 1986. Adrenoleukodystrophy: Oleic acid lowers fibroblast saturated C22–26 fatty acids. Neurology 36:357–361.
Rushton, A. R., B. A. Shaywitz, C. C. Duncan, R. B. Geehr, and E. E. Manuelidis. 1981. Computed tomography in the diagnosis of Canavan’s disease. Ann Neurol 10:57–60.
Sabatelli, M., L. Quaranta, F. Madia, G. Lippi, A. Conte, M. Lo Monaco, G. Di Trapani, M. A. Rafi, D. A. Wenger, A. M. Vaccaro, and P. Tonali. 2002. Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe’s disease. Neuromuscul Disord 12:386–391.
Sager, T. N., C. Thomsen, J. S. Valsborg, H. Laursen, and A. J. Hansen. 1999. Astroglia contain a specific transport mechanism for N-acetyl-L-aspartate. J Neurochem 73:807–811.
Sakai, N., K. Inui, M. Midorikawa, Y. Okuno, S. Ueda, A. Iwamatsu, and S. Okada. 1994. Purification and characterization of galactocerebrosidase from human lymphocytes. J Biochem (Tokyo) 116:615–620.
Sasaki, M., N. Sakuragawa, S. Takashima, S. Hanaoka, and M. Arima. 1991. MRI and CT findings in Krabbe disease. Pediatr Neurol 7:283–288.
Sauer, M., S. Grewal, and C. Peters. 2004. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses and Leukodystrophies. H ä matopoetische Stammzelltransplantation bei Kindern mit Mukopolysaccharidosen und Leukodystrophien, 163–168.
Schaumburg, H. H., J. M. Powers, C. S. Raine, P. S. Spencer, J. W. Griffin, J. W. Prineas, and D. M. Boehme. 1977. Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology 27:1114–1119.
Schaumburg, H. H., J. M. Powers, C. S. Raine, K. Suzuki, and E. P. Richardson. 1975. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 32:577–591.
Shapiro, E., W. Krivit, L. Lockman, I. Jambaque, C. Peters, M. Cowan, R. Harris, S. Blanche, P. Bordigoni, D. Loes, R. Ziegler, M. Crittenden, D. Ris, B. Berg, C. Cox, H. Moser, A. Fischer, and P. Aubourg. 2000. Long-term effect of bone-marrow transplantation for childhoodonset cerebral X-linked adrenoleukodystrophy. Lancet 356:713–718.
Shen, J. S., K. Watabe, T. Ohashi, and Y. Eto. 2001. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther 8:1081–1087.
Siddiqi, Z. A., D. B. Sanders, and J. M. Massey. 2006. Peripheral neuropathy in Krabbe disease: Effect of hematopoietic stem cell transplantation. Neurology 67:268–272.
Siemerling, E., and H. Creutzfeldt. 1923. Bronzekrankheit und sclerosierende encephalomyelitis (Diffuse Sklerose). Archiv fur Psychiatrie 68:217–244.
Surendran, S., F. J. Bamforth, A. Chan, S. K. Tyring, S. I. Goodman, and R. Matalon. 2003. Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem. J Child Neurol 18:809–812.
Suzuki, K., and K. Suzuki. 1985. Genetic galactosylceramidase deficiency (globoid cell leukodystrophy, Krabbe disease) in different mammalian species. Neurochem Pathol 3:53–68.
Suzuki, K., and K. Suzuki. 1995. The twitcher mouse: A model for Krabbe disease and for experimental therapies. Brain Pathol. 5:249–258.
Suzuki, K., and M. Taniike. 1998. Twenty five years of the “ psychosine hypothesis”: A personal perspective of its history and present status. Neurochem Res 23:251–259.
Svennerholm, L., M. T. Vanier, and J. E. Mansson. 1980. Krabbe disease: A galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21:53–64.
Tapasi, S., P. Padma, and O. H. Setty. 1998. Effect of psychosine on mitochondrial function. Indian J Biochem Biophys 35:161–165.
Theil, A. C., R. B. Schutgens, R. J. Wanders, and H. S. Heymans. 1992. Clinical recognition of patients affected by a peroxisomal disorder: A retrospective study in 40 patients. Eur J Pediatr 151:117–120.
Tonshoff, B., W. Lehnert, and H. H. Ropers. 1982. Adrenoleukodystrophy: Diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts. Clin Genet 22:25–29.
Traeger, E. C., and I. Rapin. 1998. The clinical course of Canavan disease. Pediatr Neurol 18:207–212.
Valle, D., and J. Gartner. 1993. Penetrating the peroxisome. Nature 361:682–683.
van Geel, B. M., J. Assies, E. B. Haverkort, J. H. T. M. Koelman, B. Verbeeten, Jr., R. J. A. Wanders, and P. G. Barth. 1999. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “ Lorenzo’s oil ”. J Neurol Neurosurg Psychiatry 67:290–299.
van Geel, B. M., J. Assies, R. J. A. Wanders, and P. G. Barth. 1997. X linked adrenoleukodystrophy: Clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry 63:4–14.
Vanhole, C., F. de Zegher, P. Casaer, H. Devlieger, R. J. Wanders, G. Vanhove, and J. Jaeken. 1994. A new peroxisomal disorder with fetal and neonatal adrenal insufficiency. Arch Dis Child Fetal Neonatal Ed 71:F55–56.
Verdu, P., M. Lammens, R. Dom, A. Van Elsen, and H. Carton. 1991. Globoid cel leukodystrphy: A family with both late-infantile and adult type. Neurology 41:1382–1384.
Volkow, N. D., L. Patchell, M. V. Kulkarni, K. Reed, and M. Simmons. 1987. Adrenoleukodystrophy: Imaging with CT, MRI, and PET. J Nucl Med 28:524–527.
Wanders, R. J., C. W. van Roermund, W. Lageweg, B. S. Jakobs, R. B. Schutgens, A. A. Nijenhuis, and J. M. Tager. 1992. X-linked adrenoleukodystrophy: Biochemical diagnosis and enzyme defect. J Inherit Metab Dis. 15:634–644.
Wang, C., C. M. Wang, K. R. Clark, and T. J. Sferra. 2003. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Ther 10:1528–1534.
Wenger, D. A., M. A. Rafi, and P. Luzi. 1997. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications. Hum Mutat 10:268–279.
Wenger, D. A., M. A. Rafi, P. Luzi, J. Datto, and E. Costantino-Ceccarini. 2000. Krabbe disease: Genetic aspects and progress toward therapy. Mol Genet Metab 70:1–9.
Wenger, D. A., K. Suzuki, Y. Suzuki, and K. Suzuki. 2001. Globoid cell leukodystrophy (Krabbe disease), p. 3669–3694. In AL, Beaudet, Scriver, CR, Sly WAS, Valle D, Childs B, Vogelstein B (eds.), The Metabolic and Molecular Basis of Inherited Disease, 8th ed. McGraw-Hill, New York.
Zarifi, M. K., A. A. Tzika, L. G. Astrakas, T. Y. Poussaint, D. C. Anthony, and B. T. Darras. 2001. Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe’s disease. J Child Neurol 16:522–526.
Zelnik, N., and O. N. Elpeleg. 1994. Canavan disease: Clinical-genetic correlation. Dev Med Child Neurol 36:845.
Zelnik, N., A. S. Luder, O. N. Elpeleg, V. Gross-Tsur, N. Amir, J. A. Hemli, A. Fattal, and S. Harel. 1993. Protracted clinical course for patients with Canavan disease. Dev Med Child Neurol 35:355–358.
Zu Rhein, G. M., P. L. Eichman, and F. Puletti. 1960. Familial idiocy with spongy degeneration of the central nervous system of van Bogaert — Bertrand type. Neurology 10:998–1006.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rumsey, J.W. (2009). The Genetics of Myelination in Metabolic Brain Disease: The Leukodystrophies. In: McCandless, D. (eds) Metabolic Encephalopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79112-8_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-79112-8_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79109-8
Online ISBN: 978-0-387-79112-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)